Aetion
James Miguel Pierce is a seasoned professional in the fields of science operations and pharmaceuticals, currently serving as Director at Baker Tilly Virchow Krause, LLP since May 2019 and Head of Science Operations at Aetion, Inc. since September 2016. Prior experience includes roles as Practice Leader for Pharmaceuticals at Appian Corporation and Vice President at PerimeterPharma Solutions. James Miguel Pierce also served as Global Scientific Advisor at Perceptive Informatics/Parexel. Educational qualifications include a Doctorate in Epidemiology and Psychiatry from Columbia University Vagelos College of Physicians and Surgeons, completed in 2008.
This person is not in any teams
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.